Lisinopril Price In USA

United States: 319510 USD/MT

The price of Lisinopril in Korea for Q1 2024 reached 2,530 USD/Ton in March.

The latest report by IMARC Group, titled "Lisinopril Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data," provides a thorough examination of Lisinopril Prices. This report delves into globally, presenting a detailed analysis, along with an informative price chart. Through comprehensive price analysis, the report sheds light on the key factors influencing these trends. Additionally, it includes historical data to offer context and depth to the current pricing landscape. The report also explores the demand, analyzing how it impacts market dynamics. To aid in strategic planning, the price forecast section provides insights into price forecast, making this report an invaluable resource for industry stakeholders.

Lisinopril Prices December 2023:

United States: 319510 USD/MT
Asia Pacific: 289715 USD/MT
Europe: 338740 USD/MT

Report Offering:

Monthly Updates: Annual Subscription
Quarterly Updates: Annual Subscription
Biannually Updates: Annual Subscription

The study delves into the factors affecting Lisinopril price variations, including alterations in the cost of raw materials, the balance of supply and demand, geopolitical influences, and sector-specific developments.

The report also incorporates the most recent updates from the market, equipping stakeholders with the latest information on market fluctuations, regulatory modifications, and technological progress. It serves as an exhaustive resource for stakeholders, enhancing strategic planning and forecast capabilities.

Request For a Sample Copy of the Report: https://www.imarcgroup.com/lisinopril-pricing-report/requestsample

Lisinopril Price Trend- Q4 2023

The lisinopril market is primarily driven by its widespread use in treating hypertension and heart failure. As an angiotensin-converting enzyme (ACE) inhibitor, lisinopril is a key medication for managing high blood pressure and preventing complications related to cardiovascular diseases. The increasing prevalence of hypertension and cardiovascular conditions globally boosts the demand for lisinopril. In addition to this, the market is influenced by the availability of generic versions, which typically lower prices and increase accessibility. Moreover, ongoing advancements in healthcare infrastructure, rising awareness about cardiovascular health, and growing geriatric populations also contribute to market growth. Regulatory approvals and the introduction of new formulations or delivery methods can further impact the market dynamics.

Lisinopril Industry Analysis

In Q4 2022, the North American lisinopril market experienced a price drop, attributed to reduced demand from the pharmaceutical and healthcare sectors and an oversupply situation among domestic retailers. The decline in prices was largely due to the accumulation of inventory, as domestic suppliers had previously secured substantial imports from Asia. To clear these excess stocks and stimulate demand, suppliers lowered their prices, leading to a downward trend. This reduction in prices was a direct result of the supply-demand imbalance and the strategic adjustments by suppliers to address the excess inventory situation.

In the Asia-Pacific region, the market exhibited bearish sentiments in October, but prices increased in November. This rise was driven by production halts due to the Golden Week holiday and COVID-19 restrictions, which disrupted supply and caused price escalations. Despite easing of China's zero-COVID strategy in early December, the demand for lisinopril did not significantly improve, and trading activities were subdued due to low inquiries from overseas buyers before the year-end holidays. Consequently, the prices declined again towards the end of the quarter. The market's volatility was influenced by supply chain disruptions, seasonal demand variations, and overall trading conditions.

Furthermore, in Europe, lisinopril prices initially decreased in October due to low demand from the pharmaceutical sector, particularly in Germany. However, prices rose in November, driven by reduced supply from Asian countries and inflationary pressures. Concerns about the economy and high inflation in Europe also impacted the pricing dynamics. By the end of Q4 2022, the market saw a decrease in purchasing activities, leading to a reduction in prices. This decline reflected the ongoing challenges in the European market, including fluctuating supply levels and economic uncertainties, which influenced the overall pricing trends during the quarter.

Regional Price Analysis:

Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand.
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece.
North America: United States and Canada.
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco.

Note: The current country list is selective, detailed insights into additional countries can be obtained for clients upon request

About Us:

IMARC is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145